{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:49:22Z","timestamp":1790754562646,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T00:00:00Z","timestamp":1342137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038886","type":"journal-article","created":{"date-parts":[[2012,7,14]],"date-time":"2012-07-14T05:05:18Z","timestamp":1342242318000},"page":"e38886","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Mirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System"],"prefix":"10.1371","volume":"7","author":[{"given":"Chun-Kai","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Tsang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyh-Fei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton-Ping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Yin","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Uchitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Jong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/cncr.22980","article-title":"Psychiatric disorders in advanced cancer.","volume":"110","author":"M Miovic","year":"2007","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1470-2045(06)70622-2","article-title":"Use of antidepressants and risk of colorectal cancer: A nested case-control study.","volume":"7","author":"W Xu","year":"2006","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-5347(01)67288-4","article-title":"Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines.","volume":"154","author":"M Abdul","year":"1995","journal-title":"J Urol"},{"key":"ref4","first-page":"23","article-title":"Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells.","volume":"6","author":"M Rosetti","year":"2006","journal-title":"J Exp Ther Oncol"},{"key":"ref5","first-page":"290","article-title":"The antidepressant mirtazapine-induced cytosolic Ca2+ elevation and cytotoxicity in human osteosarcoma cells. Chin.","volume":"49","author":"CC Pan","year":"2006","journal-title":"J. Physiol"},{"key":"ref6","first-page":"277","article-title":"Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice.","volume":"33","author":"I Gil-Ad","year":"2008","journal-title":"Int J Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1470-2045(07)70148-1","article-title":"Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.","volume":"8","author":"MR Stockler","year":"2007","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1200\/JCO.2009.26.9357","article-title":"Host factors and cancer progression: biobehavioral signaling pathways and interventions.","volume":"28","author":"SK Lutgendorf","year":"2010","journal-title":"J Clin Oncl"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/1078-0432.CCR-10-2441","article-title":"Dopamine blocks stress-mediated ovarian carcinoma growth.","volume":"17","author":"M Moreno-Smith","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","article-title":"The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: Effects of psychotropic drugs.","volume":"7","author":"YK Kim","year":"2002","journal-title":"Mol Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.intimp.2006.03.015","article-title":"The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.","volume":"6","author":"KM Lee","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","article-title":"Antitumor and antimetastatic activity of interleukin 12 against murine tumors.","volume":"178","author":"MJ Brunda","year":"1993","journal-title":"J Exp Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/87.8.581","article-title":"Inhibition of angiogenesis in vivo by interleukin 12.","volume":"87","author":"EE Voest","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s005200000215","article-title":"Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy.","volume":"9","author":"RE Kast","year":"2001","journal-title":"Support Care Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0885-3924(02)00381-0","article-title":"An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms.","volume":"23","author":"DE Theobald","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2354.2006.00760.x","article-title":"Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.","volume":"16","author":"RE Kast","year":"2007","journal-title":"Eur J Cancer Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00520-008-0425-1","article-title":"Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.","volume":"16","author":"ES Cankurtaran","year":"2008","journal-title":"Support Care Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1819.2007.01778.x","article-title":"Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.","volume":"62","author":"SW Kim","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine.","volume":"7","author":"SA Anttila","year":"2001","journal-title":"CNS Drug Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","article-title":"Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders.","volume":"28","author":"GJ Marek","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1049909109345685","article-title":"Phase II trial of mirtazapine for cancer-related cachexia and anorexia.","volume":"27","author":"RP Riechelmann","year":"2010","journal-title":"Am J Hospice Paliat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0885-3924(02)00381-0","article-title":"An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms.","volume":"23","author":"DE Theobald","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/CCO.0b013e3282fc734b","article-title":"Depression and cancer: Recent data on clinical issues, research challenges and treatment approaches.","volume":"20","author":"M Reich","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"ref24","article-title":"A new method for screening antidepressants in mice.","author":"L Steru","year":"1985"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S1461145702003164","article-title":"Effects of antidepressants on the production of cytokines.","volume":"5","author":"G Kenis","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"76396","DOI":"10.1155\/2007\/76396","article-title":"Pro- and anti-inflammatory cytokine balance in major depression: Effect of sertraline therapy.","volume":"2007","author":"L Sutcigil","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/039463201002300204","article-title":"The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature.","volume":"23","author":"D De Berardis","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1099\/0022-1317-81-5-1175","article-title":"Cytokine profile of draining lymph node lymphocytes in mice grafted with syngeneic keratinocytes expressing human papillomavirus type 16 E7 protein.","volume":"81","author":"MC Lopez","year":"2000","journal-title":"J Gen Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1158\/0008-5472.CAN-09-3170","article-title":"Central role of IFN-\u03b3\u2013indoleamine 2, 3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity.","volume":"70","author":"T Gu","year":"2010","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0009-9236(99)90083-8","article-title":"Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this \u201cadaptive response\u201d in mice.","volume":"65","author":"A Rakhit","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"ref31","first-page":"3559","article-title":"Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.","volume":"60","author":"R Mortarini","year":"2000","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(98)00088-8","article-title":"Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion.","volume":"20","author":"M Maes","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"ref33","first-page":"353","article-title":"In vitro immunoregulatory effects of antidepressants in healthy volunteers.","volume":"55","author":"A Szuster-Ciesielska","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"ref34","first-page":"1817","article-title":"Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms. Biochem.","volume":"75","author":"LR Frick","year":"2008","journal-title":"Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2006.04.053","article-title":"Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells.","volume":"541","author":"H Arimochi","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-2002-36390","article-title":"Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.","volume":"35","author":"T Kraus","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.pbb.2006.11.017","article-title":"Effect of acute and repeated treatment with mirtazapine on the immunity of noradrenaline transporter knockout C57BL\/6J mice.","volume":"85","author":"M Kubera","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity.","volume":"3","author":"G Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/bj3260351","article-title":"Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.","volume":"326","author":"MP Heyes","year":"1997","journal-title":"Biochem J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00115-007-2311-3","article-title":"Immunological aspects of depressive disorders.","volume":"78","author":"N M\u00fcller","year":"2007","journal-title":"Nervenarzt"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0969-8051(02)00323-2","article-title":"Biodistribution study of [<sup>123<\/sup>I]ADAM in mice: correlation with whole body autoradiography.","volume":"29","author":"KJ Lin","year":"2002","journal-title":"Nucl Med Biol"},{"key":"ref42","first-page":"673","article-title":"Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography.","volume":"45","author":"KJ Lin","year":"2004","journal-title":"J Nucl Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.pnpbp.2009.03.018","article-title":"Association between serotonin transporter availability and overall rating scores of quality of life in healthy volunteers.","volume":"33","author":"HC Tsai","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.","volume":"10","author":"C Quinten","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2967\/jnumed.109.063503","article-title":"Therapeutic efficacy evaluation of <sup>111<\/sup>In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.","volume":"50","author":"TH Chow","year":"2009","journal-title":"J Nucl Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/syn.10024","article-title":"Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats.","volume":"43","author":"L Dazzi","year":"2002","journal-title":"Synapse"},{"key":"ref47","first-page":"661","article-title":"Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.","volume":"56","author":"Z Rog\u00f3z","year":"2005","journal-title":"J Physiol Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.nucmedbio.2008.04.001","article-title":"Diagnostic and therapeutic evaluation of <sup>111<\/sup>In-vinorelbine-liposomes in a human colorectal carcinoma HT-29\/luc-bearing animal model.","volume":"35","author":"TH Chow","year":"2008","journal-title":"Nucl Med Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-009-9887-3","article-title":"Allostatic tumor-burden induces depression-associated changes in hepatoma-bearing mice.","volume":"94","author":"H Qi","year":"2009","journal-title":"J Neurooncol"},{"key":"ref50","first-page":"571","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev.","volume":"29","author":"JF Cryan","year":"2005"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T23:08:21Z","timestamp":1561936101000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038886"}},"subtitle":[],"editor":[{"given":"David L.","family":"McCormick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,13]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038886","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,13]]}}}